Hyperpituitarism: Clinical Trials

4 trials for Hyperpituitarism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 4

Follow Hyperpituitarism: new trials by email Literature Review of Hyperpituitarism trials Research Report on Hyperpituitarism

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
lanreotide - Acromegaly
Phase 4TerminatedSaint John's Cancer Institute42013-05-012021-09-30
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
Amantadine Hydrochloride, USP, Placebo - Schizophrenia, Schizoaffective Disorder
Phase 4TerminatedDavid C. Henderson, MD62009-10-012013-06-10
The Luveris In Vitro Fertilization Trial
Luveris fixed dose, Luveris increasing dose - Infertility, Hypothalamic Amenorrhea
Phase 4TerminatedUniversity Reproductive Associates142009-04-012018-08-07
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
Octreotide acetate - Acromegaly
Phase 4TerminatedNovartis Pharmaceuticals502003-03-012012-04-26

Narrower conditions

Acromegaly (2)  ·  Hyperprolactinemia (2)  ·  Gigantism (1)  ·  Infertility (1)  ·  Pituitary Neoplasms (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Endocrine System Diseases (4)  ·  Hypothalamic Diseases (4)  ·  Nervous System Diseases (4)  ·  Pituitary Diseases (4)  ·  Bone Diseases (2)  ·  Bone Diseases, Endocrine (2)  ·  Musculoskeletal Diseases (2)  ·  Bone Diseases, Developmental (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Genital Diseases (1)

Interventions

Amantadine (1)  ·  Luteinizing Hormone, beta Subunit (1)  ·  Octreotide (1)  ·  lanreotide (1)

Sponsors

David C. Henderson, MD (1)  ·  Novartis Pharmaceuticals (1)  ·  Saint John's Cancer Institute (1)  ·  University Reproductive Associates (1)

Countries

United States (3)  ·  Mexico (1)

Top investigators

Daniel F Kelly, MD (1)  ·  David C. Henderson, M.D. (1)